Targeting specific protein regions offers a new treatment approach in medulloblastoma

Scientists at St. Jude Children’s Research Hospital discovered a new compound that selectively targets parts of a cancer-related protein, EP300/CBP, in Group 3 medulloblastoma. 

Read more: https://www.stjude.org/media-resources/news-releases/2024-medicine-science-news/targeting-specific-protein-regions-offers-new-treatment-approach-medulloblastoma.html